European stocks rise as Novo Nordisk surges on US Wegovy
European stocks Novo Nordisk are benefiting from positive news, as the company's shares surge following FDA approval of its oral Wegovy, supporting market
Medicare Novo Nordisk discounts: US government secures 71%
The U.S. government announced Medicare Novo Nordisk discounts on Ozempic and Wegovy, offering a 71% price reduction to improve access and affordability for
Live: Novo Faces New Challenges After Blockbuster Success of Ozempic and Wegovy
Novo Nordisk, the Danish pharmaceutical company behind popular weight loss drugs Ozempic and Wegovy, experienced significant growth driven by the global demand for these treatments. The drugs, initially developed for…